Literature DB >> 3022868

A procedure for measuring alpha 2-adrenergic receptor-mediated inhibition of cyclic AMP accumulation in rat brain slices.

R S Duman, S J Enna.   

Abstract

The alpha 2-adrenergic receptor regulation of cyclic adenosine monophosphate (cAMP) accumulation in rat brain slices was examined. using a prelabeling technique for measuring second messenger production. The mixed alpha-adrenergic agonist 6-fluoronorepinephrine, as well as the more selective alpha 2-agonists clonidine and UK-14,304, caused a concentration-dependent inhibition of forskolin-stimulated cAMP accumulation in cerebral cortical slices, whereas phenylephrine, a selective alpha 1-adrenergic agonist, had no inhibitory effect in this system. Moreover, alpha 2-adrenergic receptor antagonists were more potent than alpha 1-adrenergic antagonists in blocking the inhibitory response to UK-14,304. Neither alpha 1- nor alpha 2-adrenergic agonists displayed any inhibitory effect when cAMP accumulation was stimulated by isoproterenol, vasoactive intestinal peptide or 2-chloroadenosine. The results provide further evidence that some alpha 2-adrenergic receptors are negatively coupled to adenylate cyclase in brain, and yield a procedure for studying this phenomenon in intact central nervous system tissue.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022868     DOI: 10.1016/0006-8993(86)91179-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Immunohistochemical localization of α2-adrenergic receptors in the neonatal rat cochlea and the vestibular labyrinth.

Authors:  Jing Cai; Jianfeng Li; Yanyan Mao; Xiaohui Bai; Lei Xu; Haibo Wang
Journal:  J Mol Neurosci       Date:  2013-08-22       Impact factor: 3.444

2.  Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice.

Authors:  P Popik; E Kozela; A Pilc
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

3.  Changes in postnatal norepinephrine alter alpha-2 adrenergic receptor development.

Authors:  J D Sanders; H K Happe; D B Bylund; L C Murrin
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

4.  Norepinephrine ignites local hotspots of neuronal excitation: How arousal amplifies selectivity in perception and memory.

Authors:  Mara Mather; David Clewett; Michiko Sakaki; Carolyn W Harley
Journal:  Behav Brain Sci       Date:  2015-07-01       Impact factor: 12.579

5.  Elevation of intracellular cyclic AMP concentration fails to inhibit adrenaline-induced hyperpolarization in amphibian sympathetic neurons.

Authors:  J A Zidichouski; M P Kehoe; K Wong; P A Smith
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

6.  Alpha 2-adrenoceptor mediated inhibition of forskolin-stimulated cyclic AMP accumulation in isolated porcine palmar lateral veins.

Authors:  I K Wright; D A Kendall; V G Wilson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

7.  Agmatine recognizes alpha 2-adrenoceptor binding sites but neither activates nor inhibits alpha 2-adrenoceptors.

Authors:  D Pinthong; I K Wright; C Hanmer; P Millns; R Mason; D A Kendall; V G Wilson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

8.  Modulation of cyclic AMP formation by putative metabotropic receptor agonists.

Authors:  J Cartmell; J A Kemp; S P Alexander; H Shinozaki; D A Kendall
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

9.  Evidence for altered alpha 2-adrenoceptor function following isolation-rearing in the rat.

Authors:  A J Fulford; S Butler; D J Heal; D A Kendall; C A Marsden
Journal:  Psychopharmacology (Berl)       Date:  1994-10       Impact factor: 4.530

10.  Potentiation by forskolin of both SNP- and ANP-stimulated cyclic GMP accumulation in porcine isolated palmar lateral vein.

Authors:  I K Wright; S Amirchetty-Rao; D A Kendall
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.